287 related articles for article (PubMed ID: 15105388)
21. Surgical staging, treatment, and follow-up of borderline tumors in different hospital categories: a prospective nationwide survey in Finland.
Kumpulainen S; Kuoppala T; Leminen A; Komulainen M; Puistola U; Sankila R; Mäkinen J; Grénman S
Acta Obstet Gynecol Scand; 2007; 86(5):610-4. PubMed ID: 17464592
[TBL] [Abstract][Full Text] [Related]
22. Successful pregnancy after conservative surgery for stage IC ovarian cancer with serous borderline tumor on controlateral ovary: a case report.
Battaglia F; Plotti F; Zullo MA; Panici PB; Plotti G
Gynecol Oncol; 2006 Mar; 100(3):612-4. PubMed ID: 16249017
[TBL] [Abstract][Full Text] [Related]
23. [Conservative management of malignant and borderline ovarian tumor].
Morice P; Camatte S; Wickart-Poque F; Rouzier R; Pautier P; Pomel C; Lhommé C; Haie-Meder C; Duvillard P; Castaigne D
Bull Cancer; 2002 Dec; 89(12):1019-26. PubMed ID: 12525360
[TBL] [Abstract][Full Text] [Related]
24. Skin metastases revealing a bilateral ovarian invasive micropapillary serous carcinoma.
Moussa A; Denguezli W; Njim L; Haddad A; Faleh R; Sakouhi M; Zakhama A
Arch Gynecol Obstet; 2008 Jul; 278(1):71-4. PubMed ID: 18066568
[TBL] [Abstract][Full Text] [Related]
25. Are borderline tumors of the ovary safely treated by laparoscopy?
Maneo A; Vignali M; Chiari S; Colombo A; Mangioni C; Landoni F
Gynecol Oncol; 2004 Aug; 94(2):387-92. PubMed ID: 15297177
[TBL] [Abstract][Full Text] [Related]
26. Fertility results and outcomes after pure laparoscopic management of advanced-stage serous borderline tumors of the ovary.
Kane A; Uzan C; Gouy S; Pautier P; Duvillard P; Morice P
Fertil Steril; 2010 Dec; 94(7):2891-4. PubMed ID: 20537629
[TBL] [Abstract][Full Text] [Related]
27. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
Silva EG; Gershenson DM; Malpica A; Deavers M
Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
[TBL] [Abstract][Full Text] [Related]
28. [Serous peritoneal papillary tumor of low malignancy potential. Report of a case].
Mayerson D; Rondini C; Braun H; Chuaqui R; Brañes J
Rev Med Chil; 2000 Feb; 128(2):206-10. PubMed ID: 10962890
[TBL] [Abstract][Full Text] [Related]
29. Prognostic factors in patients with ovarian serous low malignant potential (borderline) tumors with peritoneal implants.
Kane A; Uzan C; Rey A; Gouy S; Camatte S; Pautier P; Lhommé C; Haie-Meder C; Duvillard P; Morice P
Oncologist; 2009 Jun; 14(6):591-600. PubMed ID: 19487334
[TBL] [Abstract][Full Text] [Related]
30. [Ovarian cancer and pregnancy].
Ayoubi J; Elghaoui A; Ko Kivok-Yun P; Fournie A; Monrozies X; Reme JM
Rev Fr Gynecol Obstet; 1995; 90(7-9):335-41. PubMed ID: 7481437
[TBL] [Abstract][Full Text] [Related]
31. Conservative surgery for borderline ovarian tumors: a review.
Tinelli R; Tinelli A; Tinelli FG; Cicinelli E; Malvasi A
Gynecol Oncol; 2006 Jan; 100(1):185-91. PubMed ID: 16216320
[TBL] [Abstract][Full Text] [Related]
32. Fertility sparing treatment of recurrent stage I serous borderline ovarian tumours.
Uzan C; Muller E; Kane A; Gouy S; Bendifallah S; Fauvet R; Darai E; Morice P
Hum Reprod; 2013 Dec; 28(12):3222-6. PubMed ID: 24067602
[TBL] [Abstract][Full Text] [Related]
33. Laparoscopic fertility-sparing staging in unexpected early stage ovarian malignancies.
Muzii L; Palaia I; Sansone M; Calcagno M; Plotti F; Angioli R; Panici PB
Fertil Steril; 2009 Jun; 91(6):2632-7. PubMed ID: 18555237
[TBL] [Abstract][Full Text] [Related]
34. Fertility after conservative treatment for borderline ovarian tumors: a French multicenter study.
Fauvet R; Poncelet C; Boccara J; Descamps P; Fondrinier E; Daraï E
Fertil Steril; 2005 Feb; 83(2):284-90; quiz 525-6. PubMed ID: 15705364
[TBL] [Abstract][Full Text] [Related]
35. A need for laparoscopic evaluation of patients with endometrial carcinoma selected for conservative treatment.
Morice P; Fourchotte V; Sideris L; Gariel C; Duvillard P; Castaigne D
Gynecol Oncol; 2005 Jan; 96(1):245-8. PubMed ID: 15589610
[TBL] [Abstract][Full Text] [Related]
36. The concept of uterine preservation with ovarian malignancies.
Navot D; Fox JH; Williams M; Brodman M; Friedman F; Cohen CJ
Obstet Gynecol; 1991 Sep; 78(3 Pt 2):566-8. PubMed ID: 1870826
[TBL] [Abstract][Full Text] [Related]
37. Ovarian serous papillary cystadenocarcinoma stage IIIC in a 19-year-old.
Laframboise S; Dubuc-Lissoir J
Gynecol Oncol; 1997 Feb; 64(2):279-81. PubMed ID: 9038277
[TBL] [Abstract][Full Text] [Related]
38. [Evaluation of peritoneal extensions for the diagnosis and management of serous ovarian borderline tumors].
Andrei S; Stolnicu S; Rădulescu D; Mocan S; Puşcaşu L
Rev Med Chir Soc Med Nat Iasi; 2006; 110(3):679-86. PubMed ID: 17571566
[TBL] [Abstract][Full Text] [Related]
39. Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors): a reevaluation of the concept of stromal microinvasion.
McKenney JK; Balzer BL; Longacre TA
Am J Surg Pathol; 2006 Oct; 30(10):1209-21. PubMed ID: 17001150
[TBL] [Abstract][Full Text] [Related]
40. Outcomes of fertility-sparing surgery for invasive epithelial ovarian cancer: oncologic safety and reproductive outcomes.
Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
Gynecol Oncol; 2008 Sep; 110(3):345-53. PubMed ID: 18586310
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
